The curtain comes down at Cineworld as it shuts all its cinemas
Cinema chain Cineworld is closing its operations in Britain and America. But this crisis is not due to Covid-19 – it is largely self-induced. Matthew Partridge reports
The show’s over. Cineworld’s (LSE: CINE) share price halved this week after it confirmed that it was closing all of its UK and US cinemas, with the loss of 45,000 jobs, says Dominic Walsh in The Times. It has now fallen by 90% this year. The closures follow the announcement that the new James Bond firm, No Time to Die, has been postponed until Easter. Cineworld claims this shows that studios “are reluctant to release new blockbusters without guarantees of suitable audiences” and without such films audiences will be unwilling to “consider coming back to theatres against the backdrop of Covid-19”.
Studio bosses should stop being so myopic, says Jim Armitage in the Evening Standard. It’s true that cinemas are closed in New York and Los Angeles, where most film moguls have their “swanky pads”. But in the rest of the world, which accounts for 80% of the global box office, as well as in many US states, “cinemas have been open for months”. While some people may be reluctant to venture out, others “would love to go if there was anything worth watching”. Studios’ “ignorant trampling of decent cinema businesses” could also end up hurting them since studies show that cinema takings “massively outperform” streaming revenues.
The real culprit
There’s certainly something ironic about a film called No Time to Die “bringing down the curtain” on one of the country’s top cinema operators, says Ben Marlow in The Daily Telegraph. Still, Cineworld’s CEO, Mooky Greidinger, has hardly helped his company’s chances of survival: the chain’s debt-fuelled expansion has left it “buckling under an $8bn (£6bn) debt mountain”. It wasn’t until June that he finally abandoned the “fantasy” that he could pull off a £1.8bn takeover of Canada’s Cineplex. Overall, Cineworld needs to raise more money quickly, or it could find itself in a jam that “Bond himself would struggle to escape from”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
If Cineworld wants to borrow any more money from lenders, it will have to pay a “high price”, says Kate Burgess in the Financial Times. With the company “almost certain” to breach its loan covenants by the end of the year, it was forced to offer an interest rate of 11% on its latest tranche of debt, issued last month. Credit-ratings agency Moody’s has downgraded the group again.
With lenders wanting “nose-bleed” interest rates and UK state support “impossible”, the only other option is a rights issue, says Nils Pratley in The Guardian. However, with the company now valued at a mere £346m, it would “require the participation of... Greidinger and his trust”, which owns 20% of the shares, to raise enough money. Their capacity and inclination to inject additional funds are “unknown”. While Cineworld could benefit from a “bumper” 2021 amid the “pent-up supply” of potential blockbusters, its “path to survival in recognisable form” now seems “more uncertain than ever”.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Pension warning: one in five don’t know how much is going into their pension
How to check your pension contributions and why it matters
By Katie Williams Published
-
50,000 power of attorney applications rejected – how to avoid common mistakes
A freedom of information request shows that thousands of lasting power of attorney (LPA) applications are rejected due to errors. We explain how to avoid mistakes and reveal tips to make the process as straightforward as possible
By Ruth Emery Published
-
Investing in a dangerous world: key takeaways from the MoneyWeek Summit
If you couldn’t get a ticket to MoneyWeek’s summit, here’s an overview of what you missed
By MoneyWeek Published
-
DCC: a top-notch company going cheap
DCC has a stellar long-term record and promising prospects. It has been unfairly marked down
By Jamie Ward Published
-
How investors can use options to navigate a turbulent world
Explainer Options can be a useful solution for investors to protect and grow their wealth in volatile times.
By James Proudlock Published
-
Invest in Hilton Foods: a tasty UK food supplier
Hilton Foods is a keenly priced opportunity in an unglamorous sector
By Dr Matthew Partridge Published
-
HSBC stocks jump – is its cost-cutting plan already paying off?
HSBC's reorganisation has left questions unanswered, but otherwise the banking sector is in robust health
By Dr Matthew Partridge Published
-
Lock in an 11% yield with Sabre
Tips Sabre, a best-in-class company is undervalued due to low profits in the motor insurance industry. Should you invest?
By Rupert Hargreaves Published
-
Byju’s – the startling rise and fall
India’s educational technology start-up Byju's attracted big-name backers and soared to vertiginous heights during Covid. It has now plummeted. What happened?
By Jane Lewis Published
-
Shares in luxury goods companies take a hit – will they recover?
Luxury goods companies have run into trouble, and the odds of a rapid recovery have receded. What next?
By Dr Matthew Partridge Published